119 related articles for article (PubMed ID: 19081232)
1. Paradoxical effects of a selective cyclooxygenase-2 inhibitor, etodolac, on proliferative changes of forestomach in alloxan-induced diabetic rats.
Sano T; Ozaki K; Kodama Y; Matsuura T; Narama I
Exp Toxicol Pathol; 2009 Jul; 61(4):371-80. PubMed ID: 19081232
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial agent, tetracycline, enhanced upper alimentary tract Candida albicans infection and its related mucosal proliferation in alloxan-induced diabetic rats.
Sano T; Ozaki K; Kodama Y; Matsuura T; Narama I
Toxicol Pathol; 2012 Oct; 40(7):1014-9. PubMed ID: 22609949
[TBL] [Abstract][Full Text] [Related]
3. Effects of the antifungal agent itraconazole on proliferative changes of the forestomach mucosa in alloxan-induced diabetic rats.
Sano T; Ozaki K; Kodama Y; Matsuura T; Narama I
Toxicol Pathol; 2009 Oct; 37(6):790-8. PubMed ID: 19700660
[TBL] [Abstract][Full Text] [Related]
4. Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
Yamamoto K; Kitayama W; Denda A; Sasahira T; Kuniyasu H; Kirita T
Pathobiology; 2006; 73(6):317-24. PubMed ID: 17374970
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters.
Tsuneoka N; Tajima Y; Kitazato A; Fukuda K; Kitajima T; Kuroki T; Onizuka S; Kanematsu T
Carcinogenesis; 2005 Feb; 26(2):465-9. PubMed ID: 15498790
[TBL] [Abstract][Full Text] [Related]
6. Induction of squamous cell carcinoma of forestomach in diabetic rats by single alloxan treatment.
Kodama Y; Ozaki K; Sano T; Matsuura T; Akagi H; Narama I
Cancer Sci; 2006 Oct; 97(10):1023-30. PubMed ID: 16918997
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils.
Magari H; Shimizu Y; Inada K; Enomoto S; Tomeki T; Yanaoka K; Tamai H; Arii K; Nakata H; Oka M; Utsunomiya H; Tsutsumi Y; Tsukamoto T; Tatematsu M; Ichinose M
Biochem Biophys Res Commun; 2005 Aug; 334(2):606-12. PubMed ID: 16009342
[TBL] [Abstract][Full Text] [Related]
8. Prevention of proliferative changes of forestomach mucosa by blood glucose control with insulin in alloxan-induced diabetic rats.
Sano T; Ozaki K; Kodama Y; Matsuura T; Narama I
Cancer Sci; 2009 Apr; 100(4):595-600. PubMed ID: 19154414
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Yamamoto K; Kitayama W; Denda A; Morisaki A; Kuniyasu H; Inoue M; Kirita T
Exp Toxicol Pathol; 2004 Dec; 56(3):145-51. PubMed ID: 15625783
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.
Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Tsuneoka N; Kanematsu T
Carcinogenesis; 2008 Apr; 29(4):830-3. PubMed ID: 18296437
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats.
Takeda J; Kitajima K; Fujii S; Horiuchi H; Hori H; Chibana Y; Okuyama T; Tominaga K; Ichikawa K; Ono Y; Teramoto T; Ohkura Y; Imura J; Shinoda M; Chiba T; Sakamoto C; Kawamata H; Fujimori T
Oncol Rep; 2004 May; 11(5):981-5. PubMed ID: 15069535
[TBL] [Abstract][Full Text] [Related]
12. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT
Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928
[TBL] [Abstract][Full Text] [Related]
13. A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats.
Oba M; Miwa K; Fujimura T; Harada S; Sasaki S; Oyama K; Ohta T; Hattori T
Cancer; 2009 Jan; 115(2):454-64. PubMed ID: 19110997
[TBL] [Abstract][Full Text] [Related]
14. Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers.
Hasegawa K; Torii Y; Ishii R; Oe S; Kato R; Udagawa Y
Arch Gynecol Obstet; 2011 Dec; 284(6):1515-21. PubMed ID: 21431842
[TBL] [Abstract][Full Text] [Related]
15. A novel diabetic murine model of Candida albicans-induced mucosal inflammation and proliferation.
Sano T; Ozaki K; Terayama Y; Kodama Y; Matsuura T
J Diabetes Res; 2014; 2014():509325. PubMed ID: 24693542
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide.
Yamamoto K; Kitayama W; Denda A; Morisaki A; Kuniyasu H; Kirita T
Cancer Lett; 2003 Sep; 199(2):121-9. PubMed ID: 12969784
[TBL] [Abstract][Full Text] [Related]
17. Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1).
Hakozaki M; Hojo H; Kikuchi S; Abe M
Oncol Rep; 2007 Jan; 17(1):169-73. PubMed ID: 17143495
[TBL] [Abstract][Full Text] [Related]
18. High-grade slippage of the lumbar spine in a rat model of spondylolisthesis: effects of cyclooxygenase-2 inhibitor on its deformity.
Komatsubara S; Sairyo K; Katoh S; Sakamaki T; Higashino K; Yasui N
Spine (Phila Pa 1976); 2006 Jul; 31(16):E528-34. PubMed ID: 16845338
[TBL] [Abstract][Full Text] [Related]
19. Probiotic (yogurt) containing Lactobacillus gasseri OLL2716 is effective for preventing Candida albicans-induced mucosal inflammation and proliferation in the forestomach of diabetic rats.
Terayama Y; Matsuura T; Uchida M; Narama I; Ozaki K
Histol Histopathol; 2016 Jun; 31(6):689-97. PubMed ID: 26691696
[TBL] [Abstract][Full Text] [Related]
20. A selective cyclooxygenase-2 inhibitor (Etodolac) prevents spontaneous biliary tumorigenesis in a hamster bilioenterostomy model.
Kitasato A; Kuroki T; Adachi T; Ono S; Tanaka T; Tsuneoka N; Hirabaru M; Takatsuki M; Eguchi S
Eur Surg Res; 2014; 52(1-2):73-82. PubMed ID: 24819958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
